Critical Safety Considerations BPC-157 has not received approval from Health Canada or the US FDA for human therapeutic use
Any medication that affects glucose, lipid metabolism, growth hormone signaling, or beta-adrenergic activity could in theory interact, but evidence is absent
Increasing redness, warmth, and swelling at an injection site that worsens over 24 to 48 hours may indicate infection
And they are 3rd party lab-tested to ensure potency, purity, and quality.
Subcutaneous injections are given just under the skin
The functionally active form of thiamine is thiamine pyrophosphate which is involved in the metabolism of carbohydrates as dehydrogenases factor (ketoacidotic branched chain dehydrogenase complex piruvatodeshidrogenasa or alpha-ketoglutarate dehydrogenase) and transcetolasas